Women’s Health Diagnostic Gap

Women’s health diagnostic gap is the source’s frame for missing or weak diagnostic pathways in areas such as ovarian cancer and reproductive health. In Surbhi Sarna, Founder of nVision Medical, Surbhi Sarna first encounters the gap through severe ovarian cysts, uncertainty about whether a complex mass might be malignant, and the limited usefulness of available blood tests for premenopausal patients.

The gap is not only emotional underattention. The episode points to concrete missing infrastructure: risky biopsy routes, late cancer detection, basic data gaps around fallopian tube anatomy, and medical-device ergonomics that had not fully considered women physicians as users. [[NVisionMedical|nVision Medical]] is the company’s attempt to turn that gap into Fallopian Tube Access Diagnostics.

The concept connects to Medical Risk Management because clinicians cannot simply sample every suspicious mass if the sampling itself may spread cancer cells. It also connects to Preventive Health Screening because early detection matters, but only if the screening or sampling path is clinically safe, accurate, and validated.

Key Claims

• A diagnostic gap can exist even when patients have symptoms, physicians, imaging, and concern, because the safe next step may still be missing.
• Under-prioritization shows up in basic anatomy data, device ergonomics, category naming, and investor willingness to fund the problem.
• Better women’s-health diagnostics require product design, clinical validation, and regulatory evidence, not only awareness.
• The source treats patient need as a starting point for Founder Product Fit, but the gap becomes actionable only after physician and regulatory learning.

Connections

• Surbhi Sarna, [[NVisionMedical|nVision Medical]], and Without a Doubt - founder, company, and book branch.
• Ovarian Cancer Diagnostics, Fallopian Tube Access Diagnostics, Physician-Led Medical Device Design, and Medical Device Clinical Validation - concrete diagnostic and product path.
• Medical Risk Management, Preventive Health Screening, [[FoodAndDrugAdministration|FDA]], and Medical Testing Validation Integrity - clinical safety, screening, regulation, and validation context.